For T-cell lymphoma, high novelty targets are EDEM1, CHD3, PPP1R16B, CYFIP2, CCR7, CTPS1, HNRNPUL1, FMNL1, H3F3B, ARHGEF6, DOCK11, DIAPH1, DOCK2, CTSW, BIN2, FAM120A, and DGKZ. This evidence concerns the gene DGKZ and T-cell non-Hodgkin lymphoma.